Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.290
+0.020 (1.57%)
Jun 6, 2025, 4:08 PM HKT
-19.37%
Market Cap 1.33B
Revenue (ttm) 987.09M
Net Income (ttm) -58.09M
Shares Out 1.03B
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend 0.02 (1.87%)
Ex-Dividend Date Jun 9, 2025
Volume 77,000
Average Volume 283,325
Open 1.300
Previous Close 1.270
Day's Range 1.270 - 1.300
52-Week Range 0.930 - 1.670
Beta 0.72
RSI 46.30
Earnings Date May 28, 2025

About HKG:9960

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, maternity, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. Additionally, the company’s lab platforms comprise flow cytometry, cytogen... [Read more]

Sector Healthcare
Founded 2003
Employees 3,011
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9960
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.